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Conclusions 
Over a long period, our proton therapy facility has been reliable and 
accurate in its delivery. As the correctness of each steering file is 
anyway independently checked by a dose calculation based directly on 
the content of the steering file, we are therefore proposing to move 
to a new QA strategy. This will consist of weekly dosimetric 
verifications of only a standard and quasi-randomly selected field, to 
ensure consistency in the performance of the proton facility. This 
policy will improve workflow issues caused by the obligatory field-by-
field verification adopted up to now. 
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Purpose/Objective: During radiotherapy of the prostate, inter- and 
intra-fractional organ motion can cause deviations in prostate location 
of more than 10 mm away from the position assumed during the 
planning stage. This can potentially degrade the dose target coverage. 
In this treatment planning study we have investigated the impact on 
target coverage caused by organ motion when treating prostate 
cancer with protons, with an emphasis on the situation when 
particularly tight margins are applied. The dosimetric effects were 
compared for two the techniques Intensity Modulated Proton Therapy 
(IMPT) and passive proton Double Scattering (DS). 
Materials and Methods: CT scans of 8 prostate cancer patients were 
re-planned with IMPT and DS using the Eclipse Treatment Planning 
system (Varian Medical Systems). The prostate was defined as the 
Clinical Target Volume (CTV) and was expanded isotropically with 2 
mm to define the Planning Target Volume (PTV). The total prescribed 
dose to the PTV was 76 GyRBE and the evaluation was based on 95 % 
target dose coverage of the PTV in addition to normal tissue dose 
constraints. Both the IMPT and DS treatment plans consisted of two 
opposing lateral fields. To simulate prostate organ motion, the CTV 
was shifted 6 mm and 12 mm in posterior/anterior, superior/inferior 
and lateral directions, and plans were re-calculated for each shift 
with the original field and plan parameters.  
Results: CTV shifts in all directions caused degradation in target 
coverage, however, the degradations differed considerably between 
the two treatment techniques. For the 6 mm shifts in the anterior 
direction the mean dose coverage across all patients was reduced to 
88 ± 2 % with DS and was additionally decreased to 81 ± 4 % with IMPT. 
Similar trends were seen also for the posterior as well as the 
superior/inferior directions (Table 1). For the lateral shifts an 
opposite effect was found, with slightly larger dose reduction for DS 
compared to IMPT. The effects for 12 mm shifts were enlarged, with 
larger degradations for the anterior/posterior and superior/inferior 
directions with IMPT (Figure 1), but smaller for lateral shifts.  
 
Conclusions: In this study we have shown that prostate motion can 
cause severe reduction in target coverage. The degradations appear 
to have a higher impact when treating with IMPT than with passive DS. 
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Purpose/Objective: Although Stereotactic Ablative Body Radiotherapy 
(SABR) has become the standard treatment for T1-T2 inoperable non-
small cell lung cancer (NSCLC), the manner in which this is delivered 
may differ between institutes. Often coplanar and non-coplanar IMRT 
with 10 or more beams is performed, resulting in long treatment 
times. Image guidance, imperative for SABR increases this time even 
further, while intrafraction motion has been found to correlate with 
the overall treatment time1. Since the introduction of volumetric 
modulated arc therapy (VMAT), treatment times have been 
considerably reduced. This study aims to evaluate intrafraction 
motion in NSCLC patients treated with IMRT and VMAT based SABR. 
Materials and Methods: NSCLC patients treated with SABR(3x18 Gy) 
were consecutively selected from our database; 100 IMRT and 50 
VMAT. All patients were treated using a frameless technique whereby 
patients were positioned on a mattress with arm and knee support. 
The image guidance protocol for both techniques was identical: 1) a 
1stCBCT was acquired prior to each fraction that was registered using 
a dual registration algorithm on the bony anatomy and the tumour to 
the mid-ventilation planning CT; 2) a couch correction was performed 
to align the tumour; 3) a 2ndCBCT (CBCT2) was acquired to verify the 
correction prior to dose delivery; 4) following a non-coplanar IMRT 
technique or a dual arc VMAT technique, a 3rd CBCT (CBCT3) scan was 
acquired. Intrafraction motion was evaluated between CBCT2 and 
CBCT3. Treatment time was calculated for both techniques and was 
defined as the difference in time between CBCT3 and CBCT2. The 
difference in intrafraction motion between the 2 techniques was 
analysed in terms of the group mean, systematic and random errors. 
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Patient and tumour characteristics were analysed between the two 
groups. 
Results: The patient population in the IMRT and VMAT groups was 
similar for age, tumour location and tumour size. Although in the 
VMAT group, there were 66% males' vs 48% in de IMRT group. The 
treatment time over all fractions was reduced by ~60% from 27.5 to 
11.3 min for IMRT and VMAT respectively. Group mean, systematic and 
random errors in intrafraction bone and tumour displacement are 
shown in table 1. There was no significant difference between VMAT 
and IMRT for the tumour median vector: 0.14, 0.17 respectively 
(p=0.41). Median vector for bony anatomy, on the other hand, was 
significant for VMAT and IMRT: 0.08 and 0.14 respectively (p<0.001). 
Conclusions: Treatment time has been dramatically reduced between 
IMRT and VMAT techniques. Significant differences were found in 
intrafraction mobility of the bony anatomy but are clinically 
irrelevant. Both techniques demonstrated little intrafraction mobility 
of the tumour indicating that frameless SABR with an image guidance 
protocol can be safely administered regardless of the technique used. 
1Purdie et al., IJROBP, 2007 
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Purpose/Objective: Organ motion during respiration increases the 
component of normal tissue included within the ITV. This becomes 
particularly relevant in the use of SBRT where high doses are 
delivered across a low number of fractions. The use of abdominal 
compression (AC) aims to restrict motion of the patient’s body during 
respiration, and thus internal organ motion. With the implementation 
of SBRT at our clinic, we analysed the benefit of AC (Body Pro-Lok, 
CIVCO) with regard to reduction of both overall and distinct segmental 
motion of the liver during respiration as seen on 4DCT. 
Materials and Methods: Two 4DCTs, with and without AC, were 
performed consecutively on each of six patients receiving SBRT for 
abdominal lesions. The entire liver was then contoured using Eclipse 
Treatment Planning System on each 4DCT at the maximum and 
minimum phases of respiration. The motion of liver contours were 
analysed using an in-house program written using MATLAB. The centre 
of mass was determined as a representation of overall liver position. 
Each contour was then divided into six anatomical segments (cranial, 
caudal, anterior, posterior, left, right), and the union and intersection 
of respiratory phase contours used to calculate the range of motion 
for each individual segment. 
Results: Using AC, the mean discrepancy of liver centre of mass 
between inhalation and exhalation was reduced by 2.6mm 
(SD=2.1mm, p=0.04) in the craniocaudal plane, with residual motion 
of 6.9mm. Mean discrepancies in the lateral and anteroposterior 
planes were somewhat smaller (1.4mm and -0.5mm, respectively) and 
not significant. Analysis of distinct liver segments without AC showed 
the cranial and anterior segments to be the most unstable with mean 
respiratory motion deviations of 10.5mm and 8.4mm, respectively. 
With AC, motion deviation of the cranial segment was subsequently 
reduced by 2.8mm (SD=1.8mm, p=0.02). Deviation of the anterior 
appeared also to be reduced (1.5mm), though was not significant. 
Caudal and left liver segments demonstrated moderate motion 
without AC (6.3mm and 7.3mm, respectively), while the posterior and 
right liver segments were shown to be most stable (2.7mm and 4.4mm 
motion, respectively). Change in motion with AC was not significant 
for any of these segments. 
Conclusions: Use of AC reduced the range of overall liver motion 
predominantly in the craniocaudal plane. On more detailed analysis, 
the cranial region of the liver was seen to demonstrate the largest 
range of respiratory motion, which could be significantly attenuated 
by AC. Motion of all other regions were unaffected by use of AC. The 
further accumulation and analysis of such data will help guide the 
selection of patients that have the most to gain from AC, while 
sparing those that would not benefit from the discomfort and 
extended set-up time involved. On-treatment CBCT imaging is also 
being analysed to contribute data regarding the effect of AC upon 
patient and target volume position reproducibility during treatment. 
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Purpose/Objective: A remaining uncertainty in breast cancer 
irradiation is the effect of respiratory induced motion on target area 
and organs at risk. In case of whole breast irradiation (WBI) 
respiratory induced motion will have hardly any impact on coverage of 
the target area. Even coverage of the boost area is ensured since 
almost 90% of the total dose is delivered via tangential fields of the 
WBI. However, in partial breast irradiation (PBI), uncertainties in 
correct definition of the target area and its localization during 
treatment can lead to a geographical miss.  
In literature, several surrogates have been used to evaluate 
respiratory induced motion; e.g. clips/markers, chest wall, using 3D 
or 4DCT data. Also motion differences within targets have been 
described. To summarize all respiratory induced motion for target 
area and organs at risk within one patient, we used 4DCT data and 
selected different regions of interest (ROIs). 
Materials and Methods: For ten patients two CT scans were acquired; 
a 3DCT scan for planning purposes and a 4D respiratory correlated CT 
scan to investigate intrafraction motion due to respiration. The 4DCT 
scan was reconstructed into ten equal phases, each phase 
corresponding with one breathing cycle.  
To rule out patient motion between the 3D and 4DCT scan, the 4DCT 
scan was first registered to the planning CT scan on bony anatomy 
(spinal cord). Second, each phase of the 4DCT scan was registered to 
the planning CT, based on 8 different ROIs: (1) Ribs and a part of the 
sternum, (2) heart, (3) breast surface, (4) tumour bed, (5-8) four 
quadrants of the breast. 
For ROI (1) a bony anatomy registration based on a chamfer matching 
algorithm was performed. For ROIs (2-8) masks were created on the 
planning CT. Anatomical landmarks or surgical clips were used for the 
mask registrations of the four breast quadrants and demonstrated a 
surrogate for tumour position. The mask registrations were based on 
grey values. For each patient and each ROI (1-8), the mean (M) and 
standard deviation (SD) of the motion errors were calculated, as well 
as the amplitude of the motion. 
Results: For all ROIs, except the heart, the M magnitude of the 
breathing motion was <0.05 cm. Systematic errors of all ROIs were 
between 0.03-0.05 cm in LR, 0.09-0.22 cm in CC and 0.08-0.15 cm in 
AP direction. The amplitude of the motion was 0.09-0.11 cm in LR, 
0.18-0.26 cm in CC and 0.14-0.20 cm in AP direction (table 1). No 
difference was found between the quadrants of the breast. 
Considerable motion of the heart was seen in particular in the CC 
direction: the M motion was 0.11 cm (SD 0.45 cm) and the mean 
amplitude 1.18 cm. 
 
Conclusions: Large respiratory induced motion was found for the 
heart: in cases where the treatment beams are close to the heart an 
organ at risk margin is required. For all other ROIs the motion was 
very small. In case of PBI, the additional margin required to account 
for respiratory induced motion of the target area will therefore be 
negligible. 
 
 
 
